Interpace Biosciences Inc IDXG:OTCQX

*Data is delayed | Exchange | USD
Last | 05/13/24 EDT
1.45UNCH (UNCH)
Volume
14,883
52 week range
0.76 - 3.54
Loading...
  • Open1.37
  • Day High1.52
  • Day Low1.37
  • Prev Close1.45
  • 52 Week High3.54
  • 52 Week High Date07/11/23
  • 52 Week Low0.76
  • 52 Week Low Date08/24/23

Key Stats

  • Market Cap6.346M
  • Shares Out4.38M
  • 10 Day Average Volume3,510
  • Dividend-
  • Dividend Yield-
  • Beta0.69
  • YTD % Change34.26

KEY STATS

  • Open1.37
  • Day High1.52
  • Day Low1.37
  • Prev Close1.45
  • 52 Week High3.54
  • 52 Week High Date07/11/23
  • 52 Week Low0.76
  • 52 Week Low Date08/24/23
  • Market Cap6.346M
  • Shares Out4.38M
  • 10 Day Average Volume3,510
  • Dividend-
  • Dividend Yield-
  • Beta0.69
  • YTD % Change34.26

RATIOS/PROFITABILITY

  • EPS (TTM)0.25
  • P/E (TTM)5.81
  • Fwd P/E (NTM)-2.46
  • EBITDA (TTM)3.83M
  • ROE (TTM)-3,669.04%
  • Revenue (TTM)40.213M
  • Gross Margin (TTM)59.44%
  • Net Margin (TTM)2.77%
  • Debt To Equity (MRQ)-61.73%

EVENTS

  • Earnings Date08/11/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Interpace Biosciences Inc

 

Profile

MORE
Interpace Biosciences, Inc. provides personalized medicine and offers specialized services along the therapeutic value chain from early diagnosis and prognostic planning to targeted therapeutic applications. Its clinical services, through Interpace Diagnostics, provide clinically useful molecular diagnostic tests, bioinformatics and pathology services for evaluating the risk of cancer by leveraging the technology in personalized medicine for improved patient diagnosis and...
Thomas Burnell Ph.D.
President, Chief Executive Officer, Director
Christopher Mccarthy
Chief Financial Officer
Address
Waterview Plaza
Suite 310, 2001 Route 46
Parsippany, NJ
07054
United States

Top Peers

SYMBOLLASTCHG%CHG
AIRS
Airsculpt Technologies Inc
4.67-0.07-1.48%